Researcher Database | Faculty of Pharmaceutical Sciences Department of Pharmacy

Sumio Chono

Department / Course Hokkaido University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy

Job Professor

Academic conference presentation
2019/07	Efficient delivery to fibrotic regions of liposomes modified with fibroblast- and collagen-targeting peptides for the treatment of idiopathic pulmonary fibrosis (Controlled Release Society 2019 Annual Meeting & Exposition, Valencia, Spain)
2019/07	Multiscale live-imaging using F?rster resonance energy transfer to evaluate the distribution of nanoparticles for drug delivery (Controlled Release Society 2019 Annual Meeting & Exposition, Valencia, Spain)
2018/11	Multi-scale imaging using F?rster resonance energy transfer for evaluating drug carrier distribution (2018 AAPS PharmSci 360， Washington DC， USA.)
2017/07	Influence of extracellular matrix in fibrotic lesions on the distribution of aerosolized drugs (Drug Discovery and Therapy World Congress 2017, Boston, USA)
2015/10	Altered intrapulmonary pharmacokinetics of aerosolized drugs due to the disruption of the alveolar epithelial barrier in animals with bleomycin-induced pulmonary fibrosis (2015 AAPS Annual Meeting and Exposition, Orlando, FL, USA)
2014/10	Intrapulmonary pharmacokinetics of aerosolized drugs in animals with bleomycin-induced pulmonary fibrosis (19th North American ISSX / 29th JSSX Meeting（San Francisco, CA）)
2014/06	Surface-modified immuno-liposomes as carriers for drug delivery to macrophages in atherosclerotic lesions (Drug Discovery and Therapy World Congress 2014, Boston, USA)
2013/06	Efficacy of aerosolized PEGylated liposomes as carriers for drug delivery to alveolar epithelial lining fluid (Drug Discovery and Therapy World Congress 2013, Boston, USA)
2011/06	Distribution Mechanisms of Macrolide Antibiotics in Lung Epithelial Lining Fluid and Alveolar Macrophages for the Therapy of Respiratory Infections (8th Retrometabolic Drug Design and Targeting Conference, Graz, Austria)
2011/04	Intrapulmonary distribution mechanisms of macrolide and ketolide antibiotics for the treatment of respiratory infections (4th ASIA PACIFIC REGIONAL MEETING OF ISSX, Tainan, Taiwan)
2011/04	Pharmacokinetic and pharmacodynamic assessment of AUC/MIC of intrapulmonary administered macrolide antimicrobial agents for optimizing the treatment of respiratory infections (4th ASIA PACIFIC REGIONAL MEETING OF ISSX, Tainan, Taiwan)
2010/12	Distribution mechanisms of macrolide antibiotics in lung epithelial lining fluid and alveolar macrophages for the therapy of respiratory infections (3rd Indo-Japanese international joint symposium on overcoming interactive diseases prevalent in Asian countries, Tokyo)
2010/11	Distribution mechanisms of macrolide antibiotics in lung epithelial lining fluid and alveolar macrophages for the therapy of respiratory infections (2010 AAPS Annual Meeting and Exposition, New Orleans, LA, USA)
2009/11	Distribution mechanisms of macrolide antibiotics in lung epithelial lining fluid and alveolar macrophages for the therapy of respiratory infections (2009 AAPS Annual Meeting and Exposition, Los Angeles, CA, USA)
2009/08	Quassinoids isolated from a medicinal plant, Brucea javanica and their antitrypanosomal activities in vitro (WAAVP, Calgary, Canada)
2008/09	Pharmacokinetical analysis of telithromycin in lung for safe therapy of respiratory infections (World congress of pharmacy and pharmaceutical sciences 2008 68th International congress of FIP, Basel, Switzerland)
2008/07	Antitumor and Mechanistic Study on siRNA Containing LPD Nanoparticles (11th LIPOSOME RESEARCH DAYS CONFERENCE, Yokohama)
2008/07	Efficient antibiotic delivery to alveolar macrophages by pulmonary administration of mannosylated liposomes for treatment of respiratory infection (11th LIPOSOME RESEARCH DAYS CONFERENCE, Yokohama)
2008/07	siRNA delivery to the metastatic tumor (35th Controlled Release Society Annual Meeting & Exposition, New York, USA)
2007/11	Efficacy of pulmonary administration of telithromycin for the treatment of respiratory infection (First Indo-Japanese International Joint Symposium on Overcoming Intractable Infection Diseases Prevalent in Asian Countries, Tokyo)
2007/11	Pharmacokinetics of telithromycin in lung surface and alveolar macrophages (2007 AAPS Annual Meeting and Exposition, San Diego, CA, USA)
2007/11	Pulmonary administration system of ciprofloxacin incorporated into liposomes for treatment of respiratory intracellular parasite infection (First Indo-Japanese International Joint Symposium on Overcoming Intractable Infection Diseases Prevalent in Asian Countries, Tokyo)
2007/07	Pulmonary administration system of antibiotics incorporated into liposomes (34th Annual Meeting and Exposition of the Controlled Release Society, Long Beach, CA, USA)
2007/07	Pulmonary administration system of antibiotics incorporated into liposomes for treatment of respiratory intracellular parasite infections (1st Asian Pharmaceutical Science and Technology Symposium, Shenyang, China)
2007/06	Cationic polymer as absorption enhancers for pulmonary administration of peptide drugs (6th Retrometabolism based drug design and targetion conference, God, Hungary)
2006/07	Development of drug delivery system by dexamethasone incorporated into liposomes for atherosclerotic therapy (33rd Annual Meeting & Exposition of the Controlled Release Society, Vienna, Austria)
2005/12	Novel injectable cationic microspheres based on aminated gelatin for prolonged action of inslin (8th US-Japan Symposium on Drug Delivery Systems, Hawaii, USA)
2005/05	Novel injectable cationic microspheres based on aminated gelatin for prolonged action of inslin (5th Retrometabolism Based Drug Design and Targeting Conference, Hakone, Japan)
2004/11	Design of Novel Injectable Sustained Release Cationized Microspheres Based on Aminate Gelatin for Insulin Delivery (2004 AAPS Annual Meeting and Exposition, Baltimore, USA)
2004/06	Aminated gelatin as nasal absorption enhancer for peptide drugs (Pharmaceutical Sciences World Cngress 2004, Kyoto)
2002/09	Effect of dexamethasone palmitate-low densicty lipoprotein complex as a drug-carrier on experimental atherosclerosis (FIP Congress 2002, Nice, France)
2000/04	Design of liposomal preparation of dexamethasone for atherosclerosis therapy (MILLENIAL WORLD CONGRESS of PHARMACEUTICAL SCIENCES, San Francisco, USA)